Recordati Industria Chimica e Farmaceutica S.p.A. (RECN)
BMV
Closed
Oct 6, 2026
Day's Range
1,019.7952 wk Range
944.72Overview - RECN - Recordati Industria Chimica e Farmaceutica S.p.A.
Key Statistics
Valuation
Enterprise Value
4.33T
P/E (Trailing)
‪21.73‬
Price / Sales (TTM)
‪77.20‬
Price / Book
‪4.94‬
EV / EBITDA
‪207.85‬
Profitability
Gross Margin
‪71.40%‬
Profit Margin
‪18.37%‬
Operating Margin
‪29.19%‬
Return on Assets
‪9.77%‬
Return on Equity
‪24.85%‬
Ownership
Shares Outstanding
204.81M
Float
101.82M
Held by Insiders
‪46.82%‬
Held by Institutions
‪32.51%‬
Price stats
Beta
‪0.53‬
50-Day Avg
‪1,019.79‬
200-Day Avg
‪1,051.33‬
Dividends
Payout Ratio
‪56.29%‬
Frequency
Semi-Annual
Market Cap - RECN - Recordati Industria Chimica e Farmaceutica S.p.A.
Peers - RECN - Recordati Industria Chimica e Farmaceutica S.p.A.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BMV.
- RECNBMVRecordati Industria Chimica e Farmaceutica S.p.A.208.86BMarket Cap+7.36%52-week change21.74P/E (Trailing)‪18.37%‬Profit Margin
- LLYBMVEli Lilly and Company18.13TMarket Cap+23.00%52-week change40.03P/E (Trailing)‪33.52%‬Profit Margin
- JNJBMVJohnson & Johnson11.56TMarket Cap+30.79%52-week change31.69P/E (Trailing)‪21.48%‬Profit Margin
- ABBVBMVAbbVie Inc.8.48TMarket Cap+11.51%52-week change75.55P/E (Trailing)‪9.80%‬Profit Margin
- MRKBMVMerck & Co., Inc.6.48TMarket Cap+45.13%52-week change121.93P/E (Trailing)‪4.76%‬Profit Margin
- ROP1NBMVRoche Holding AG5.94TMarket Cap-0.31%52-week change23.09P/E (Trailing)‪19.60%‬Profit Margin
- NOVNNBMVNovartis AG Registered Shares4.94TMarket Cap+13.28%52-week change22.68P/E (Trailing)‪22.50%‬Profit Margin
Profile Summary - RECN - Recordati Industria Chimica e Farmaceutica S.p.A.
About
Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical company specializing in the development, manufacturing, and commercialization of innovative medicines across specialty and primary care, consumer healthcare, and rare diseases. Headquartered in Milan, Italy, it traces its origins to a…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
